SCHEMBL4725398

SCHEMBL4725398

COCCCNC(=O)c1cnn2c(C)c(Cc3ccccc3)c(C)nc12

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.73
KDM4E B2RXH2 7/20 0.73
LMNA P02545 12/20 0.67
TP53 P04637 10/20 0.67
MAPT P10636 6/20 0.66
HPGD P15428 6/20 0.65
SMN1; SMN2 Q16637 3/20 0.65
MEN1 O00255 2/20 0.65
HTT P42858 2/20 0.65
KMT2A Q03164 2/20 0.65
HSD17B10 Q99714 5/20 0.58
MAPK1 P28482 2/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
NPSR1 Q6W5P4 3/20 0.55
TSHR P16473 2/20 0.54
USP2 O75604 1/20 0.54
ALOX12 P18054 1/20 0.54
POLB P06746 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4795070 0.95 ALDH1A1 (0.77) ALDH1A1KDM4ELMNATP53MAPT
SCHEMBL4793796 0.92 ALDH1A1 (0.67) ALDH1A1KDM4ELMNATP53MAPT
SCHEMBL902276 0.91 ALDH1A1 (0.61) ALDH1A1KDM4ELMNATP53MAPT
SCHEMBL4779322 0.91 KDM4E (0.68) ALDH1A1KDM4ELMNATP53MAPT
SCHEMBL4779270 0.90 LMNA (0.73) ALDH1A1KDM4ELMNATP53MAPT
SCHEMBL4780215 0.89 KDM4E (0.60) ALDH1A1KDM4ELMNATP53MAPT
SCHEMBL4796244 0.89 KDM4E (0.74) ALDH1A1KDM4ELMNATP53MAPT
SCHEMBL4778100 0.89 KDM4E (0.59) ALDH1A1KDM4ELMNATP53MAPT
SCHEMBL4781908 0.89 LMNA (0.66) ALDH1A1KDM4ELMNATP53MAPT
SCHEMBL4794797 0.88 KDM4E (0.57) ALDH1A1KDM4ELMNATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221129-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-09-11 US claimed
WO-2008003753-A1 PYRAZOLO [1,5-A] PYRIMIDINE ANALOGS FOR USE AS INHIBITORS OF STEAROYL-COA DESATURASE (SCD) ACTIVITY BIOVITRUM AB (PUBL) (SE) 2008-01-10 WO claimed
US-20080221129-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-09-11 US disclosed
WO-2008003753-A1 PYRAZOLO [1,5-A] PYRIMIDINE ANALOGS FOR USE AS INHIBITORS OF STEAROYL-COA DESATURASE (SCD) ACTIVITY BIOVITRUM AB (PUBL) (SE) 2008-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221129-A1 New compounds SCD, SCD5, FASN ALDH1A1 858/4885KDM4E 3813/4885LMNA 2075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.